Formal literature review of quality-of-life instruments used in end- stage renal disease

American Journal of Kidney Diseases

Volumn 36, Issue 2, 2000, Pages 327-336

  Cagney, Kathleen A ^a,b,c,d   Wu, Albert ^a,b,c,d   Fink, Nancy E ^a,b,c,d   Jenckes, Mollie W ^a,b,c,d   Meyer, Klemens B ^a,b,c,d   Bass, Eric B ^a,b,c,d   Powe, Neil R ^a,b,c,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Instrument development; Quality of life (QOL); Quality of care measurement in ESRD

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; DEPRESSION; FUNCTIONAL ASSESSMENT; HUMAN; KIDNEY FAILURE; MEASUREMENT; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; QUALITY OF LIFE;

EID: 0034255829     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.8982     Document Type: Article

References (103)

1. Rettig RA, Sadler JH, Meyer KB, Wasson JH, Parkerson GR, Kantz B, Hays RD, Patrick DL: Assessing health and quality-of-life outcomes in dialysis: A report to an Institute of Medicine Workshop. Am J Kidney Dis 30:140-155, 1997
2. Patrick DL, Erickson P: Health Status and Health Policy: Allocating Resources to Health Care. New York, NY, Oxford University Press, 1993
3. US Renal Data System: USRDS 1999 Annual Data Report. The National Institutes of Health, Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD, 1999
4. US Bureau of the Census: Current Population Reports, Special Studies, P23-190, 65 + in the United States. Washington, DC, US Government Printing Office, 1996
5. Gill TM, Feinstein AR: A critical appraisal of the quality-of-life measurements. JAMA 272:619-626, 1994
6. McDowell I, Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. New York, NY, Oxford University Press, 1996
7. McHorney C, Tarlov AR: Individual patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 4:293-307, 1995
8. Sanders C, Egger M, Donovan J, Tallon D, Frankel S: Reporting on quality of life in randomised controlled trials: Bibliographic study. BMJ 317:1191-1194, 1998
9. Hornquist JO, Wikby A, Stenstrom U, Andersson PO, Akerlind I: Type II diabetes and quality of life: A review of the literature. Pharmacoeconomics 8:12-16, 1995
10. Lehman AF: Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol 31:78-88,1996
11. Solomon GD: Evolution of the measurement of quality of life in migraine. Neurology 48:S10-S15, 1996 (suppl 3)
12. Edgell ET, Coons SJ, Carter WB, Kallich JD, Maes D, Damush TM, Hays RD: A review of health-related quality-of-life measures used in end-stage renal disease. Clin Ther 18:887-938, 1996
13. Evans RW, Manninen DL, Garrison LP, Hart G, Blagg CR, Gutman RA, Hull AR, Lowrie EG: The quality of life of patients with end-stage renal disease. N Engl J Med 312:553-559, 1985
14. Avram MR, Pena C, Burrell D, Antignani AM, Avram MM: Hemodialysis and the elderly patient: Potential advantages as to quality of life, urea generation, serum creatinine, and less interdialytic weight gain. Am J Kidney Dis 16:342-345, 1990
15. Simmons RG, Anderson CR, Abress LK: Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol Suppl 131:S7-S22, 1990
16. Powe NR, Turner JA, Maklan C, Ersek M: Alternative methods for formal literature review and meta-analysis in AHCPR patient outcomes research teams. Med Care 32: JS22-JS37, 1994
17. Bennett KJ, Torrance GW: Measuring health state preferences and utilities: Rating scale, time trade-off, and standard gamble techniques, in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA, Lippincott-Raven, 1996, pp 253-265
18. Deyo RA, Diehr P, Patrick DL: Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials 12:S142-S158, 1991 (suppl 4)
19. Aday LA: Designing and Conducting Health Surveys. San Francisco, CA, Jossey-Bass, 1996
20. Guyatt GH, Bombardier C, Tugwell PX: Measuring disease-specific quality of life in clinical trials. Can Med Assoc J 134:889-895, 1986
21. Guyatt GH, Jaeschke R, Feeny DH, Patrick DL: Measurements in clinical trials: Choosing the right approach, in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA, Lippincott-Raven, 1996, pp 41-48
22. Abram HS, Hester LR, Sheridan WF, Epstein GM: Sexual functioning in patients with chronic renal failure. J Nerv Ment Dis 160:220-226, 1975
23. Anderson JE, Kraus J, Sturgeon D: Incidence, prevalence, and outcomes of end-stage renal disease patients placed in nursing homes. Am J Kidney Dis 21:619-627, 1993
24. Auer J, Gokal R, Stout JP, Hillier VF, Kincey J, Simon LG, Oliver DO: The Oxford-Manchester study of dialysis patients. Age, risk factors and treatment method in relation to quality of life. Scand J Urol Nephrol Suppl 131:S31-S37,1990
25. Auer J, Oliver DO, Winearls CG: The quality of life of dialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol Suppl 131:S61-S65, 1990
26. Badia X, Alonso J, Brosa M, Lock P: Reliability of the Spanish version of the Nottingham Health Profile in patients with stable end-stage renal disease. Soc Sci Med 38:153-158,1994
27. Barany P, Pettersson E, Konarski-Svensson JK: Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Nephrol Dial Transplant 8:426-432, 1993
28. Barrett BJ, Vavasour HM, Major A, Parfrey PS: Clinical and psychological correlates of somatic symptoms in patients on dialysis. Nephron 55:10-15, 1990
29. Bergamo Collaborative Dialysis Study Group: Acute intradialytic well-being: Results of a clinical trial comparing polysulfone with cuprophan. Kidney Int 40:714-719, 1991
30. Binik YM, Baker AG, Kalogeropolulos D, Devins GM, Guttmann RD, Hollomby DJ, Barre PE, Hutchison T, Prud'Homme M, McMullen L: Pain, control over treatment, and compliance in dialysis and transplant patients. Kidney Int 21:840-848, 1982
31. Björvell H, Hylander B: Functional status and personality in patients on chronic dialysis. J Intern Med 226:319-324, 1989
32. Bremer BA, Haffly D, Foxx RM, Weaver A: Patients' perceived control over their health care: An outcome assessment of their psychological adjustment to renal failure. Am J Med Qual 10:149-154, 1995
33. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 300:573-578, 1990
34. Cardenas DD, Kutner NG: The problem of fatigue in dialysis patients. Nephron 30:336-340, 1982
35. Carlson DM, Johnson WJ, Kjellstrand CM: Functional status of patients with end-stage renal disease. Mayo Clinic Proc 62:338-344, 1987
36. Christensen AJ, Turner CW, Smith TW, Holman JM Jr, Gregory MC: Health locus of control and depression in end-stage renal disease. J Consult Clin Psychol 59:419-424, 1991
37. Chubon R: Quality of life and persons with end-stage renal disease. Dial Transplant 15:450-452, 1986
38. Churchill DN, Bird DR, Taylor DW, Beecroft ML, Gorman J, Wallace JE: Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol 12:412-418, 1992
39. Churchill DN, Morgan J, Torrance GW: Quality of life in end-stage renal disease. Perit Dial Bull 4:10-23, 1984
40. Craven J, Littlefield C, Rodin G, Murray M: The end-stage renal disease severity index (ESRD-SI). Psychol Med 21:237-243, 1991
41. Deniston OL, Carpentier-Alting P, Kneisley J, Hawthorne VM, Port FK: Assessment of quality of life in end-stage renal disease. Health Serv Res 24:555-578, 1989
42. Devins GM, Beanlands H, Mandin H, Paul LC: Psychosocial impact of illness intrusiveness moderated by self-concept and age in end-stage renal disease. Health Psychol 16:529-538, 1997
43. Devins GM, Edworthy SM, Paul LC, Mandin H, Seland TP, Klein G, Costello CG, Shapiro CM: Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: Rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res 27:163-170,1993
44. Devins GM, Mann J, Mandin H, Paul LC, Hons RB, Burgess ED, Taub K, Shorr S, Letourneau PK, Buckle S: Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis 178:127-133, 1990
45. Evans RW: Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: A comparative analysis. Am J Kidney Dis 18:62-70, 1991
46. Evans RW, Rader B, Manninen DL: The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 263:825-830, 1990
47. Fox E, Peace K, Neale TJ, Morrison RB, Hatfield PJ, Mallsop G: "Quality of life" for patients with end-stage renal failure. Ren Fail 13:31-35, 1991
48. Groome PA, Hutchinson TA, Tousignant P: Content of a decision analysis for treatment choice in end-stage renal disease: Who should be consulted? Med Decis Making 14:91-97, 1994
49. Gudex CM: Health-related quality of life in end-stage renal failure. Qual Life Res 4:359-366, 1995
50. Harris LE, Luft FC, Rudy DW, Tierney WM: Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis 21:161-166, 1993
51. Hart LG, Evans RW: The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chron Dis 40:S117-S130, 1987 (suppl 1)
52. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB: Development of the Kidney Disease Quality of Life (KDQOL) instrument. Qual Life Res 3:329-338, 1994
53. Hornberger JD, Redelmeier DA, Petersen J: Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 45:55-512, 1992
54. Johnson JP, McCauley CR, Copley JB: The quality of life of hemodialysis and transplant patients. Kidney Int 22:285-291, 1982
55. Juergensen PH, Juergenson DM, Wuerth DB, Finkelstein SH, Steele TE, Kliger AS, Finkelstein FO: Psychosocial factors and incidence of peritonitis. Adv Perit Dial 12:196-198, 1996
56. Kaplan De-Nour A, Shanan J: Quality of life of dialysis and transplanted patients. Nephron 25:117-120, 1980
57. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 54:245-254, 1998
58. Klang B, Björvell H, Berglund J, Sundstedt C, Clyne N: Predialysis patient education: Effects on functioning and well-being in uraemic patients. J Adv Nurs 28:36-44, 1998
59. Klang B, Clyne N: Well-being and functional ability in uraemic patients before and after having started dialysis treatment. Scand J Caring Sci 11:159-166, 1997
60. Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME: Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program. Med Care 30:MS136-MS149, 1992
61. Kutner NG, Brogan D, Fielding B: Employment status and ability to work among working-age chronic dialysis patients. Am J Nephrol 11:334-340, 1991
62. Kutner NG, Brogan DJ: Assisted survival, aging, and rehabilitation needs: Comparison of older dialysis patients and age-matched peers. Arch Phys Med Rehabil 73:309-315, 1992
63. Laupacis A: Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. Semin Nephrol 10:11-19, 1990
64. Laupacis A, Muirhead N, Keown P, Wong C: A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 60:302-306, 1992
65. Laupacis A, Wong C, Chruchill D, and The Canadian Erythropoietin Study Group: The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. Control Clin Trials 12:S168-S179, 1991 (suppl 4)
66. Levin NW: Quality of life and hematocrit level. Am J Kidney Dis 20:16-20, 1992
67. Levin NW, Lazarus JM, Nissenson AR: National Cooperative rHu Erythropoietin Study in patients with chronic renal failure -An interim report. The National Cooperative rHu Erythropoietin Study Group. Am J Kidney Dis 22:3-12, 1993
68. Levy NB, Wynbrandt GD: The quality of life on maintenance haemodialysis. Lancet 1:1328-1330, 1975
69. McClellan WM, Anson C, Birkeli K, Turtle E: Functional status and quality of life: Predictors of early mortality among patients entering treatment for end-stage renal disease. J Clin Epidemiol 44:83-89, 1991
70. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT: Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. Am J Kidney Dis 29:584-592, 1997
71. Meyer KB, Espindle DM, Degiacomo JM, Jenuleson CS, Kurtin PS, Davies AR: Monitoring dialysis patient's health status. Am J Kidney Dis 24:267-279, 1994
72. Moizahan AE, Northcott HC, Hayduk L: Quality of life of patients with end-stage renal disease: A structural equation model. Qual Life Res 5:426-432, 1996
73. Moreno F, Aracil FJ, Perez R, Valderrábano F: Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis 27:548-556, 1996
74. Morris KP, Sharp J, Watson S, Coulthard MG: Non-cardiac benefits of human recombinant erythropoietin in end-stage renal failure and anaemia. Arch Dis Child 69:580-586, 1993
75. Morris PL, Jones B: Life satisfaction across treatment methods for patients with end-stage renal failure. Med J Aust 150:428-432, 1989
76. Morris PL, Jones B: Transplantation versus dialysis: A study of quality of life. Transplant Proc 20:23-26, 1988
77. Mozes B, Shabtai E: The contribution of personal rating to the clinimetric functioning of a generic quality-of-life instrument. J Clin Epidemiol 49:1419-1422, 1996
78. Nissenson AR: Recombinant human erythropoietin: Impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Semin Nephrol 9:25-31, 1989
79. Parfrey PS, Vavasour H, Bullock M, Henry S, Harnett JD, Gault MH: Symptoms in end-stage renal disease: Dialysis v transplantation. Transplant Proc 14:3407-3409, 1987
80. Parfrey PS, Vavasour H, Bullock M, Henry S, Harnett JD, Gault MH: Development of a health questionnaire specific for end-stage renal disease. Nephron 52:20-28, 1989
81. Parfrey PS, Vavasour HM, Gault HM: A prospective study of health status in dialysis and transplant patients. Transplant Proc 20:1231-1232, 1988
82. Parfrey PS, Vavasour H, Henry S, Bullock M, Gault MH: Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron 50:121-128, 1988
83. Pollak VE, Pesce A, Kant KS: Continuous quality improvement in chronic disease: A computerized medical record enables description of a severity index to evaluate outcomes in end-stage renal disease. Am J Kidney Dis 19:514-522, 1992
84. Rosa AA, Fryd DS, Kjellstrand CM: Dialysis symptoms and stabilization in long-term dialysis: Practical application of the CUSUM plot. Arch Intern Med 140:804-807, 1980
85. Sesso R, Yoshihiro MM, Ajzen H: Late diagnosis of chronic renal failure and the quality of life during dialysis treatment. Braz J Med Biol Res 29:1283-1289, 1996
86. Sesso R, Yoshihiro MM: Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant 12:2111-2116, 1997
87. Simmons RG, Abress L: Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis 15:201-208, 1990
88. Simmons RG, Anderson BA, Kamstra L: Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation. Am J Kidney Dis 4:253-255, 1984
89. Simmons RG, Anderson CR, Kamstra LK, Ames NG: Quality of life and alternate end-stage renal disease therapies. Transplant Proc 17:1577-1578, 1985
90. Siskind MS, Lien YH: Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs 16:599-603, 1993
91. Steele TE, Baltimore D, Finkelstein SH, Juergensen P, Kliger AS, Finkelstein FO: Quality of life in peritoneal dialysis patients. J Nerv Ment Dis 184:368-374, 1996
92. Stevens JM, Auer J, Strong CA, Hughes RT, Oliver DO, Winearls CG, Cotes PM: Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 6:494-497, 1991
93. Tell GS, Mittelmark MB, Hylander B, Shumaker SA, Russell GB, Burkart JM: Social support and health-related quality of life in black and white dialysis patients. ANNA J 22:301-310, 1995
94. US Recombinant Human Erythropoietin Predialysis Study Group: Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group [published erratum, Am J Kidney Dis 18:420, 1991]. Am J Kidney Dis 18:50-59, 1991
95. Walker S, Fine A, Kryger MH: Sleep complaints are common in a dialysis unit. Am J Kidney Dis 26:751-756, 1995
96. Wolcott DL, Nissenson AR: Quality of life in chronic dialysis patients: A critical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Am J Kidney Dis 11:402-412, 1988
97. Hunt SM, McEwan J, McKenna SP: Measuring Health Status. London, England, Croom Helm, 1986
98. Campbell A, Converse PE, Rogers WL: The Quality of American Life: Perceptions, Evaluations and Satisfactions. New York, NY, Russell Sage Foundation, 1976
99. Bergner M, Bobbitt RA, Carter WB, Gilson BS: The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19:787-805, 1981
100. Torrance GW, Thomas WH, Sackett DL: A utility maximization model for evaluation of health care programs. Health Serv Res 7:118-133, 1972
101. Bass E, Jenckes J, Fink N, Cagney K, Wu A, Powe N: Use of focus groups to identify concerns about dialysis. Med Decis Making 19:287-295, 1999
102. Dickersin K: The existence of publication of publication bias and risk factors for its occurrence. JAMA 263: 1385-1389, 1990
103. van Campen C, Sixma H, Friele RD, Kerssens JJ, Peters L: Quality of care and patient satisfaction: A review of measuring instruments. Med Care Res Rev 52:109-133, 1995